PubMed Health⌕ Search

Biomedical subjects

R Packard

Publications and source records attributed to R Packard.

12 recordsLinked to original sources

Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin.

PURPOSE: To describe the use of intracameral phenylephrine to prevent the floppy iris syndrome seen in patients who are on the drug tamsulosin for benign prostatic hypertrophy, during cataract surgery. SETTING: Prince Charles Eye Unit, King Edward VII Hospital, Windsor, Berkshire, UK. METHOD: Seven patients who were on systemic tamsulosin for benign prostatic hypertrophy received intracameral phenylephrine before capsulorexhis during their cataract surgery. RESULTS: There was a significant reduction in the amount of mobility of the iris, reduction in the expected fluttering, and sustained papillary dilatation. ConclusionIntracameral phenylephrine is a simple and effective tool to prevent the effects of floppy iris syndrome in those patients undergoing cataract surgery who are on systemic tamsulosin.

Adrenergic alpha-1 Receptor Antagonists↗

A commitment to community.

Retiring Republican Member of Congress for the 48th District of California, Dr. Ron Packard reflects on the qualities of success that are common in dentistry and politics and stresses the importance of community.

California↗

Onchocerciasis.

Explore the source record for details and available documents.

Communicable Disease Control↗

The serum-free growth of cultured cells in bovine colostrum and in milk obtained later in the lactation period.

Seven established cell lines, including both epithelial cells and fibroblasts (MDCK, Vero, CV-1, NRK, 3T3, F2408, and NIL8) and four early passage cell strains (bovine articular chondrocytes, bovine smooth muscle cells, human foreskin fibroblasts, and rat embryo cells) were cultured in serum-free medium supplemented with milk obtained 1 day after birth (colostrum) or 80 days after birth (older milk). MDCK, Vero, CV-1, NRK, and 3T3 grew readily in colostrum and attained saturation densities ranging from 22% to 63% of that in serum. There was no growth of F2408, NIL8, or the early passage strains in bovine colostrum. None of the 11 cell cultures grew in older milk. The temporal dependence of growth in milk was examined in detail using MDCK cells. Growth equivalent to that in serum occurred in 3% colostrum and in 15% milk obtained 2 days after birth. Milk obtained 3 days and 10 days after birth was not effective as a growth supplement for MDCK cells at any concentration. Those cells, unable to grow in colostrum or in older milk, could be induced to grow if culture dishes were precoated with fibronectin. In addition to fibronectin, it was necessary in some cultures to supplement colostrum or older milk with insulin and/or transferrin in order to achieve growth. In the presence of fibronectin and appropriate factors, the final saturation density attained in colostrum or older milk ranged from 25% to 100% of that in serum. The fibronectin contents of bovine colostrum and milk were determined. The fibronectin level of colostrum was found to be approximately 5% of bovine serum. There was no detectable fibronectin in the 80-day-old milk.

Animals↗